Do Analysts Agree Friday on NantHealth Inc (NH) Stock's Target Price?

Friday, January 21, 2022 02:22 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Friday on NantHealth Inc (NH) Stock's Target Price?

Wall Street is positive on NantHealth Inc (NH). On average, analysts give NantHealth Inc a Strong Buy rating. The average price target is $3.25, which means analysts expect the stock to climb by 273.56% over the next twelve months. That average ranking earns NantHealth Inc an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating NH a Strong Buy today. Find out what this means to you and get the rest of the rankings on NH!

See Full NH Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With NantHealth Inc Stock Today?

NantHealth Inc (NH) stock is higher by 3.68% while the S&P 500 has fallen -0.89% as of 2:21 PM on Friday, Jan 21. NH is higher by $0.03 from the previous closing price of $0.84 on volume of 161,108 shares. Over the past year the S&P 500 has risen 15.31% while NH has fallen -76.61%. NH lost -$0.55 per share the over the last 12 months. Click Here to get the full Stock Report for NantHealth Inc stock.